Exhibit 24
POWER OF ATTORNEY
The undersigned hereby authorizes and appoints Donald E. Morel, Jr. and John R. Gailey III, and each of them, as his attorneys-in-fact to sign on his behalf and in his capacity as a director of West Pharmaceutical Services, Inc., and to file, the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2004 and all amendments, exhibits and supplements thereto.
/s/ Tenley E. Albright, M.D. |
Tenley E. Albright, M.D. |
Date:March 8, 2005
POWER OF ATTORNEY
The undersigned hereby authorizes and appoints Donald E. Morel, Jr. and John R. Gailey III, and each of them, as his attorneys-in-fact to sign on his behalf and in his capacity as a director of West Pharmaceutical Services, Inc., and to file, the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2004 and all amendments, exhibits and supplements thereto.
/s/ George W. Ebright |
George W. Ebright |
Date:March 8, 2005
POWER OF ATTORNEY
The undersigned hereby authorizes and appoints Donald E. Morel, Jr. and John R. Gailey III, and each of them, as his attorneys-in-fact to sign on his behalf and in his capacity as a director of West Pharmaceutical Services, Inc., and to file, the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2004 and all amendments, exhibits and supplements thereto.
/s/ L. Robert Johnson |
L. Robert Johnson |
Date:March 7, 2005
POWER OF ATTORNEY
The undersigned hereby authorizes and appoints Donald E. Morel, Jr. and John R. Gailey III, and each of them, as his attorneys-in-fact to sign on his behalf and in his capacity as a director of West Pharmaceutical Services, Inc., and to file, the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2004 and all amendments, exhibits and supplements thereto.
/s/ William H. Longfield |
William H. Longfield |
Date:March 7, 2005
POWER OF ATTORNEY
The undersigned hereby authorizes and appoints Donald E. Morel, Jr. and John R. Gailey III, and each of them, as his attorneys-in-fact to sign on his behalf and in his capacity as a director of West Pharmaceutical Services, Inc., and to file, the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2004 and all amendments, exhibits and supplements thereto.
/s/ John P. Neafsey |
John P. Neafsey |
Date:March 7, 2005
POWER OF ATTORNEY
The undersigned hereby authorizes and appoints Donald E. Morel, Jr. and John R. Gailey III, and each of them, as his attorneys-in-fact to sign on his behalf and in his capacity as a director of West Pharmaceutical Services, Inc., and to file, the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2004 and all amendments, exhibits and supplements thereto.
/s/ Anthony Welters |
Anthony Welters |
Date:March 7, 2005
POWER OF ATTORNEY
The undersigned hereby authorizes and appoints Donald E. Morel, Jr. and John R. Gailey III, and each of them, as his attorneys-in-fact to sign on his behalf and in his capacity as a director of West Pharmaceutical Services, Inc., and to file, the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2004 and all amendments, exhibits and supplements thereto.
/s/ Geoffrey F. Worden |
Geoffrey F. Worden |
Date:March 7, 2005
POWER OF ATTORNEY
The undersigned hereby authorizes and appoints Donald E. Morel, Jr. and John R. Gailey III, and each of them, as his attorneys-in-fact to sign on his behalf and in his capacity as a director of West Pharmaceutical Services, Inc., and to file, the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2004 and all amendments, exhibits and supplements thereto.
/s/ Robert C. Young, M.D. |
Robert C. Young, M.D. |
Date:March 7, 2005
POWER OF ATTORNEY
The undersigned hereby authorizes and appoints Donald E. Morel, Jr. and John R. Gailey III, and each of them, as his attorneys-in-fact to sign on his behalf and in his capacity as a director of West Pharmaceutical Services, Inc., and to file, the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2004 and all amendments, exhibits and supplements thereto.
/s/ Patrick J. Zenner |
Patrick J. Zenner |
Date:March 7, 2005